Avui a la Jornada 'Sumem dades, Multipliquem Coneixements' de @vallhebron parlant de Real World Data (RWD) i medicina personalitzada en oncologia. @VHIO
Participem en la Jornada 'Sumem dades, Multipliquem Coneixements' de @vallhebron.
@aapedrol ha format part de la taula rodona on s’ha presentat la plataforma VHTeDades, creada per #VallHebron per assegurar un entorn segur per gestionar tot el cicle de vida de les dades.
Day 4 of #EWAC2024 focuses on Digital Health and Care. @aapedrol, Data Engineering for Research Unit Lead and @CancerCoreEU#CCEDART, dives into the cutting-edge tech transforming cancer research and treatment. Innovation for better patient outcomes‼️
#EUProject
Today we celebrated the first day of #CCEAM24 in Milan, Italy. After a review, perspectives and strategic session, attendees enjoyed great flash talks. Looking forward to day 2!
#CCEDART
📢 Posició de bioestadístic/a per treballar a @VHIO .
🔍Es busca algú amb motivació per aprendre, amb vocació per l’estadística i interessada en aplicar-la en l’àmbit de la recerca oncològica.
Més informació:
https://t.co/D7qJpxk12D
https://t.co/VfOkmYGa3T
@socestadistica
Congratulations @krys987@aapedrol for the endless effort of keeping OncoTrialsTrack active and up-to-date, a friendly tool for physicians looking for precision oncology trial opportunities through @EUCANCan_ sponsorship!
Such a great pleasure, to present OncoTrialsTrack (https://t.co/8woIMr0bU6) at Clinical Trials Summit in Madrid.
Thanks to all the Odyssey team from @VHIO, the @EUCANCan_ project and specially @rdienstmann and @aapedrol
Tomorrow at 2pm, I'll be presenting OncoTrialsTrack at CTS Summit (Madrid).
A clinical trials locator developed by @rdienstmann, @aapedrol and myself within the @EUCANCan_ project at @VHIO
⚠️Visit: https://t.co/8woIMqIAvw
El Grupo ODysSey del VHIO promueve la investigación traslacional en oncología de precisión mediante la integración de datos de perfiles moleculares del cáncer con los resultados clínicos de los pacientes oncológicos tratados en @vallhebron.
https://t.co/EXffYWXBsu
#ClínicaVHIO
👉 Final preps for my talk at @ASCO on "Depersonalized Medicine and Genomics: What Are We Missing?"
🔜 Monday, 6th June, 3 pm, Room S102
🤔 WHAT ELSE ARE WE MISSING? @oncoclinicas@VHIO
🥳NEW #OGiPpublication in #Bioinformatics from @OxfordJournals!
Check the PanCancer ImmunoGenomics (#PCIG), a new tool that yields an integrative analysis of the crosstalk between somatic genomic alterations and different immune features.
More details 👇
I am pleased to introduce PCIG: a web-based tool to explore immune-genomics interactions. A collaboration between @idibaps and @VHIO recently published at Bioinformatics by @aapedrol and @bb_laia. https://t.co/05d5B0uaop
Delighted to share PCIG: a web-based tool to explore immune-genomics interactions.
🔗Publication: https://t.co/cO86XeFYCn
🔧Tool: https://t.co/mPUx5NhZQK
spanning across 20 different cancer primary sites. PCIG yields an integrative analysis of the crosstalk between somatic genomic alterations and different immune features, thus helping to understand immune response-related processes.